{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:18:54Z","timestamp":1788787134113,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Glycogen storage disease (GSD) Ia, caused by mutations in the glucose-6-phosphatase (<jats:italic>G6PC<\/jats:italic>) gene, is characterized by hepatomegaly, hypoglycemia, lactic acidosis, dyslipidemia, and hyperuricemia. This study aimed to investigate clinical and molecular features and late complications in Korean patients with GSD Ia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fifty-four Korean patients (33 males and 21 females) from 47 unrelated families, who were diagnosed with GSD Ia, based on genetic and biochemical data, between 1999 and 2017, were included in this study. The median age at diagnosis was 3.9\u2009years (range: 5\u2009months to 42\u2009years), and the follow-up period was 8.0\u2009\u00b1\u20096.8\u2009years. Most patients presented with hepatomegaly during infancy, but hypoglycemic symptoms were not predominant. Genetic analysis showed that all the patients had at least one c.648G\u2009&gt;\u2009T allele. Homozygous c.648G\u2009&gt;\u2009T mutations in the <jats:italic>G6PC<\/jats:italic> gene were identified in 34 families (72.3%), and compound heterozygotes with c.648G\u2009&gt;\u2009T were found in the other families. The allele frequency of c.648G\u2009&gt;\u2009T was 86.2% (81\/94), and p.F51S, p.R83H, p.G122D, p.Y128*, p.G222R, and p.T255A were identified. Of 26 adult patients, 14 had multiple hepatic adenomas, and two were diagnosed with hepatocellular carcinoma. Thirteen patients showed renal complications, and seven patients presented gout, despite preventive allopurinol treatment. Twelve patients had osteoporosis, and two patients had pulmonary hypertension. The final heights were 157.9\u2009cm (standard deviation score: \u2212\u20093.1) in males and 157.8\u2009cm (standard deviation score: \u2212\u20090.6) in females.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In our Korean patients with GSD Ia, the most common mutation in the <jats:italic>G6PC<\/jats:italic> gene was c.648G\u2009&gt;\u2009T, suggesting a founder effect. Because of only mild hypoglycemia, the patients tended to be diagnosed late. Thus, adult patients with GSD Ia eventually developed diverse and serious complications, which indicates a need for careful monitoring and proper management of this disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-1321-0","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T15:02:51Z","timestamp":1581433371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Predominance of the c.648G &gt; T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia"],"prefix":"10.1186","volume":"15","author":[{"given":"Yoo-Mi","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Mo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8615-186X","authenticated-orcid":false,"given":"Han-Wook","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"1321_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1750-1172-6-27","volume":"6","author":"R Froissart","year":"2011","unstructured":"Froissart R, Piraud M, Boudjemline AM, Vianey-Saban C, Petit F, Hubert-Buron A, et al. Glucose-6-phosphatase deficiency. Orphanet J Rare Dis. 2011;6:27.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1321_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3109\/01913123.2011.601404","volume":"35","author":"J Hicks","year":"2011","unstructured":"Hicks J, Wartchow E, Mierau G. Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment. Ultrastruct Pathol. 2011;35(5):183\u201396.","journal-title":"Ultrastruct Pathol"},{"issue":"2","key":"1321_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/ng0696-203","volume":"13","author":"KJ Lei","year":"1996","unstructured":"Lei KJ, Chen H, Pan CJ, Ward JM, Mosinger B Jr, Lee EJ, et al. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat Genet. 1996;13(2):203\u20139.","journal-title":"Nat Genet"},{"issue":"2","key":"1321_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/1566524024605798","volume":"2","author":"JY Chou","year":"2002","unstructured":"Chou JY, Matern D, Mansfield BC, Chen YT. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med. 2002;2(2):121\u201343.","journal-title":"Curr Mol Med"},{"issue":"Suppl 1","key":"1321_CR5","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1007\/s00431-002-0997-6","volume":"161","author":"SW Moses","year":"2002","unstructured":"Moses SW. Historical highlights and unsolved problems in glycogen storage disease type 1. Eur J Pediatr. 2002;161(Suppl 1):S2\u20139.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1321_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.7326\/0003-4819-120-3-199402010-00008","volume":"120","author":"GM Talente","year":"1994","unstructured":"Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, et al. Glycogen storage disease in adults. Ann Intern Med. 1994;120(3):218\u201326.","journal-title":"Ann Intern Med"},{"issue":"5133","key":"1321_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.8211187","volume":"262","author":"KJ Lei","year":"1993","unstructured":"Lei KJ, Shelly LL, Pan CJ, Sidbury JB, Chou JY. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science. 1993;262(5133):580\u20133.","journal-title":"Science."},{"issue":"5","key":"1321_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/jhg.2013.17","volume":"58","author":"J Kido","year":"2013","unstructured":"Kido J, Nakamura K, Matsumoto S, Mitsubuchi H, Ohura T, Shigematsu Y, et al. Current status of hepatic glycogen storage disease in Japan: clinical manifestations, treatments and long-term outcomes. J Hum Genet. 2013;58(5):285\u201392.","journal-title":"J Hum Genet"},{"issue":"6","key":"1321_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1399-0004.2004.00260.x","volume":"65","author":"CS Ki","year":"2004","unstructured":"Ki CS, Han SH, Kim HJ, Lee SG, Kim EJ, Kim JW, et al. Mutation spectrum of the glucose-6-phosphatase gene and its implication in molecular diagnosis of Korean patients with glycogen storage disease type Ia. Clin Genet. 2004;65(6):487\u20139.","journal-title":"Clin Genet"},{"issue":"3","key":"1321_CR10","first-page":"549","volume":"57","author":"S Kajihara","year":"1995","unstructured":"Kajihara S, Matsuhashi S, Yamamoto K, Kido K, Tsuji K, Tanae A, et al. Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan. Am J Hum Genet. 1995;57(3):549\u201355.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1321_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/(SICI)1096-8628(20000313)91:2<107::AID-AJMG5>3.0.CO;2-Y","volume":"91","author":"J Akanuma","year":"2000","unstructured":"Akanuma J, Nishigaki T, Fujii K, Matsubara Y, Inui K, Takahashi K, et al. Glycogen storage disease type Ia: molecular diagnosis of 51 Japanese patients and characterization of splicing mutations by analysis of ectopically transcribed mRNA from lymphoblastoid cells. Am J Med Genet. 2000;91(2):107\u201312.","journal-title":"Am J Med Genet"},{"issue":"3","key":"1321_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1399-0004.1998.tb02674.x","volume":"53","author":"CW Lam","year":"1998","unstructured":"Lam CW, But WM, Shek CC, Tong SF, Chan YS, Choy KW, et al. Glucose-6-phosphatase gene (727G-->T) splicing mutation is prevalent in Hong Kong Chinese patients with glycogen storage disease type 1a. Clin Genet. 1998;53(3):184\u201390.","journal-title":"Clin Genet"},{"issue":"Suppl 1","key":"1321_CR13","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1007\/s00431-002-0999-4","volume":"161","author":"JP Rake","year":"2002","unstructured":"Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr. 2002;161(Suppl 1):S20\u201334.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"1321_CR14","first-page":"766","volume":"57","author":"KJ Lei","year":"1995","unstructured":"Lei KJ, Chen YT, Chen H, Wong LJ, Liu JL, McConkie-Rosell A, et al. Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus. Am J Hum Genet. 1995;57(4):766\u201371.","journal-title":"Am J Hum Genet"},{"issue":"Suppl 1","key":"1321_CR15","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1007\/s00431-002-0998-5","volume":"161","author":"D Matern","year":"2002","unstructured":"Matern D, Seydewitz HH, Bali D, Lang C, Chen YT. Glycogen storage disease type I: diagnosis and phenotype\/genotype correlation. Eur J Pediatr. 2002;161(Suppl 1):S10\u20139.","journal-title":"Eur J Pediatr"},{"issue":"12","key":"1321_CR16","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1046\/j.1440-1746.2001.02645.x","volume":"16","author":"T Nakamura","year":"2001","unstructured":"Nakamura T, Ozawa T, Kawasaki T, Nakamura H, Sugimura H. Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors. J Gastroenterol Hepatol. 2001;16(12):1402\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1321_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/2251-6581-12-25","volume":"12","author":"PM Carvalho","year":"2013","unstructured":"Carvalho PM, Silva NJ, Dias PG, Porto JF, Santos LC, Costa JM. Glycogen storage disease type Ia - a secondary cause for hyperlipidemia: report of five cases. J Diabetes Metab Disord. 2013;12(1):25.","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"1321_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jhep.2010.03.002","volume":"53","author":"D Cassiman","year":"2010","unstructured":"Cassiman D, Libbrecht L, Verslype C, Meersseman W, Troisi R, Zucman-Rossi J, et al. An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia. J Hepatol. 2010;53(1):213\u20137.","journal-title":"J Hepatol"},{"issue":"1","key":"1321_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.gene.2012.07.057","volume":"509","author":"JJ Shieh","year":"2012","unstructured":"Shieh JJ, Lu YH, Huang SW, Huang YH, Sun CH, Chiou HJ, et al. Misdiagnosis as steatohepatitis in a family with mild glycogen storage disease type Ia. Gene. 2012;509(1):154\u20137.","journal-title":"Gene."},{"issue":"Suppl 1","key":"1321_CR20","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1007\/BF02680007","volume":"161","author":"JP Rake","year":"2002","unstructured":"Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP, et al. Guidelines for management of glycogen storage disease type I - European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr. 2002;161(Suppl 1):S112\u20139.","journal-title":"Eur J Pediatr"},{"issue":"11","key":"1321_CR21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/gim.2014.128","volume":"16","author":"PS Kishnani","year":"2014","unstructured":"Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014;16(11):e1.","journal-title":"Genet Med"},{"issue":"4","key":"1321_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/jhn.12030","volume":"26","author":"KK Shah","year":"2013","unstructured":"Shah KK, O'Dell SD. Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis. J Hum Nutr Diet. 2013;26(4):329\u201339.","journal-title":"J Hum Nutr Diet"},{"issue":"11","key":"1321_CR23","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.2215\/CJN.00050109","volume":"4","author":"DH Martens","year":"2009","unstructured":"Martens DH, Rake JP, Navis G, Fidler V, van Dael CM, Smit GP. Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition. Clin J Am Soc Nephrol. 2009;4(11):1741\u20136.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"16","key":"1321_CR24","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.2169\/internalmedicine.49.3425","volume":"49","author":"T Araoka","year":"2010","unstructured":"Araoka T, Takeoka H, Abe H, Kishi S, Araki M, Nishioka K, et al. Early diagnosis and treatment may prevent the development of complications in an adult patient with glycogen storage disease type Ia. Intern Med. 2010;49(16):1787\u201392.","journal-title":"Intern Med"},{"issue":"2","key":"1321_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10545-005-7500-2","volume":"28","author":"LM Franco","year":"2005","unstructured":"Franco LM, Krishnamurthy V, Bali D, Weinstein DA, Arn P, Clary B, et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis. 2005;28(2):153\u201362.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"1321_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00261-011-9721-1","volume":"37","author":"A Sakamoto","year":"2012","unstructured":"Sakamoto A, Hayashi H, Sakamoto I, Isomoto I, Eguchi S, Takatsuki M, et al. Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA. Abdom Imaging. 2012;37(2):239\u201343.","journal-title":"Abdom Imaging"},{"issue":"6","key":"1321_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4254\/wjh.v4.i6.191","volume":"4","author":"Y Mikuriya","year":"2012","unstructured":"Mikuriya Y, Oshita A, Tashiro H, Amano H, Kobayashi T, Arihiro K, et al. Hepatocellular carcinoma and focal nodular hyperplasia of the liver in a glycogen storage disease patient. World J Hepatol. 2012;4(6):191\u20135.","journal-title":"World J Hepatol"},{"issue":"10","key":"1321_CR28","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1253\/circj.CJ-08-0181","volume":"73","author":"M Ueno","year":"2009","unstructured":"Ueno M, Murakami T, Takeda A, Kubota M. Efficacy of oral sildenafil in a beraprost-treated patient with severe pulmonary hypertension secondary to type I glycogen storage disease. Circ J. 2009;73(10):1965\u20138.","journal-title":"Circ J"},{"issue":"6","key":"1321_CR29","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s10545-018-0200-5","volume":"41","author":"M Herbert","year":"2018","unstructured":"Herbert M, Pendyal S, Rairikar M, Halaby C, Benjamin RW, Kishnani PS. Role of continuous glucose monitoring in the management of glycogen storage disorders. J Inherit Metab Dis. 2018;41(6):917\u201327.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"1321_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijns3020006","volume":"3","author":"Peter Schielen","year":"2017","unstructured":"Schielen P, Kemper EA, Gelb MH. Newborn Screening for Lysosomal Storage Diseases: A Concise Review of the Literature on Screening Methods, Therapeutic Possibilities and Regional Programs. Int J Neonatal Screen. 2017;3(2). https:\/\/doi.org\/10.3390\/ijns3020006.","journal-title":"International Journal of Neonatal Screening"},{"issue":"2","key":"1321_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/1073110516654133","volume":"44","author":"N Kelly","year":"2016","unstructured":"Kelly N, Makarem DC, Wasserstein MP. Screening of newborns for disorders with high benefit-risk ratios should be mandatory. J Law Med Ethics. 2016;44(2):231\u201340.","journal-title":"J Law Med Ethics"},{"issue":"10","key":"1321_CR32","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1093\/hmg\/ddx097","volume":"26","author":"GY Kim","year":"2017","unstructured":"Kim GY, Kwon JH, Cho JH, Zhang L, Mansfield BC, Chou JY. Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy. Hum Mol Genet. 2017;26(10):1890\u20139.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1321_CR33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/jimd.12056","volume":"42","author":"JH Cho","year":"2019","unstructured":"Cho JH, Lee YM, Starost MF, Mansfield BC, Chou JY. Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage. J Inherit Metab Dis. 2019;42(3):459\u201369.","journal-title":"J Inherit Metab Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1321-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-1321-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1321-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T01:02:08Z","timestamp":1612918928000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-1321-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-1321-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"assertion":[{"value":"5 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consents were obtained from patients and the parents of each patient, and this study was approved by the Research Ethics Board at the Asan Medical Center (approval number: S2019\u20131025-0001).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}